Organizational Announcement

We are pleased to announce that Dr. Art Taveras has joined the company as President and Chief Scientific Officer (CSO), effective Oct. 24th, 2013. Dr. Taveras brings extensive pharmaceutical leadership and technical expertise in all aspects of Drug Discovery, Chemistry R&D and Pharmaceutical Development having served as a Pharmaceutical and Biotech Executive during his 24-year career. As President and CSO, Dr. Taveras will establish ShangPharma as the premiere Drug Discovery and Development partner of Pharmaceutical and Biotechnology companies worldwide.

October 26, 2013

 

Frontier Forum – Collaboration and Partnership in Novel Therapeutics

Chempartner and Shanghai Institute for Advanced Immunochemical Studies (SIAIS) will jointly host “Frontier Forum – Collaboration and Partnership in Novel Therapeutics” in Shanghai at the end of Oct.

August 23, 2013

Pages